David C. Sachs

Insider Reports History

Entity
Individual
Location
C/O Immunitybio, Inc., 3530 John Hopkins Court, San Diego, CA
Signature
/s/ Jason Liljestrom, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David C. Sachs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunityBio, Inc. Chief Financial Officer Common Stock 186K $624K $3.36 Jan 31, 2024 Direct
ImmunityBio, Inc. Chief Financial Officer Restricted Stock Units 122K $493K $4.04 Feb 22, 2024 Direct
ImmunityBio, Inc. Chief Financial Officer Stock Option (right to buy) 424K Feb 22, 2024 Direct

Insider Reports Filed by David C. Sachs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IBRX ImmunityBio, Inc. Feb 22, 2024 2 $0 4 Feb 26, 2024 Chief Financial Officer
IBRX ImmunityBio, Inc. Jan 31, 2024 3 -$90.2K 4 Feb 2, 2024 Chief Financial Officer
IBRX ImmunityBio, Inc. Dec 31, 2023 3 -$52.8K 4 Jan 3, 2024 Chief Financial Officer
IBRX ImmunityBio, Inc. Sep 1, 2023 2 $0 4 Sep 6, 2023 Chief Financial Officer
IBRX ImmunityBio, Inc. Aug 25, 2023 1 $0 4 Aug 28, 2023 Chief Financial Officer
IBRX ImmunityBio, Inc. Dec 31, 2022 2 $0 4 Jan 4, 2023 Chief Financial Officer
IBRX ImmunityBio, Inc. Mar 23, 2022 2 $0 4 Mar 25, 2022 Chief Financial Officer
IBRX ImmunityBio, Inc. Dec 9, 2021 2 $0 4 Dec 13, 2021 Chief Financial Officer
IBRX ImmunityBio, Inc. Sep 9, 2021 2 $0 4 Sep 13, 2021 Chief Financial Officer